NASDAQ •
Healthcare •
Biotechnology •
Quote as of 05/27/2026
Company Profile
IndustryBiotechnology
SectorHealthcare
ExchangeNASDAQ
Market Capitalization23.05 mln
Float15.79 mln
Earnings Date05/12/2026
Piotroski F-Score
2
/ 9
Weak
Relative Strength
99
/ 100
Top performer
Debt / Equity
0.00
Debt-free
ROE
-147
Deeply negative
Dividend Yield
0.00%
No dividend
DPS
0.00
No dividend
Business Description
Hoth Therapeutics is a New York-based biopharmaceutical company founded in 2017 that works to create new treatments for conditions that currently lack effective medical solutions. The company has several drugs in development targeting a wide range of health problems, including skin disorders, traumatic brain injury, Alzheimer's disease, cancer, asthma, allergies, lupus, and eczema. Hoth advances its research through licensing partnerships with several universities and biotechnology firms, drawing on external expertise to support its drug development programs.
